F-11440

CAS No. 179756-58-2

F-11440 ( Eptapirone )

Catalog No. M12716 CAS No. 179756-58-2

A potent, selective 5-HT1A receptor agonist with Ki of 4.8 nM, pKi of 8.33.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 76 In Stock
10MG 129 In Stock
25MG 255 In Stock
50MG 473 In Stock
100MG 673 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    F-11440
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective 5-HT1A receptor agonist with Ki of 4.8 nM, pKi of 8.33.
  • Description
    A potent, selective 5-HT1A receptor agonist with Ki of 4.8 nM, pKi of 8.33; shows ≥shows 100-fold higher affinity for the other serotonin receptor subtypes, and has no detectable antidopaminergic activity and antihistaminergic activity; decreases the forskolin-induced increase in AMP in HeLa cells expressing human 5-HT1A receptors; produces anxiolytic- and antidepressant-like effects in animal models.Anxiety Phase 1 Discontinued
  • Synonyms
    Eptapirone
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1A
  • Research Area
    Neurological Disease
  • Indication
    Anxiety

Chemical Information

  • CAS Number
    179756-58-2
  • Formula Weight
    345.40
  • Molecular Formula
    C16H23N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6 mg/mL (Need ultrasonic)
  • SMILES
    O=C(N1C)N(CCCCN2CCN(C3=NC=CC=N3)CC2)N=CC1=O
  • Chemical Name
    1,2,4-Triazine-3,5(2H,4H)-dione, 4-methyl-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Koek W, et al. J Pharmacol Exp Ther. 1998 Oct;287(1):266-83.
2. Prinssen EP, et al. Eur J Pharmacol. 2002 Oct 25;453(2-3):217-21.
3. Pauwels PJ, et al. J Pharmacol Exp Ther. 2003 Nov;307(2):608-14.
molnova catalog
related products
  • Cerlapirdine

    Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.

  • Olanzapine

    Olanzapine is an atypical antipsychotic, approved by the FDA in 1996.

  • Velusetrag hydrochlo...

    Velusetrag (TD-5108) is a potent, selective and oral 5-HT4 receptor agonist with pKi of 7.7, shows >500-fold selectivity over other 5-HT receptors.